READER QUESTION: Track Botulinum Wastage for Accurate Coding

Why This Topic Matters

Accurate reporting of administered and discarded drug amounts affects claim completeness, compliance, and reimbursement. The article highlights that payer policy can vary, so readers need to recognize documentation and reporting differences before submitting claims.

Article Sections

1. Question and answer on botulinum toxin wastage

   Introduces the billing question and provides general guidance on documenting waste for injectable botulinum toxin use.

2. Example involving botulinum toxin procedures and billing units

   Uses a worked example to illustrate how botulinum toxin services may be reported across two patients and how administered and discarded amounts are handled in practice.

3. Medicare manual guidance and documentation expectations

   Summarizes Medicare-related guidance on discarded amounts and emphasizes the need for documentation of dosage and wastage details.

4. Payer-specific reporting practices and modifier use

   Describes variation among payers in how discarded drug amounts are reported and notes that some carriers require separate reporting formats.

5. Final note on checking payer policy

   Ends with a reminder that billing policies for wasted drugs should be verified with the payer.